Seuraa
Khachen Kongpakwattana, Ph.D.
Khachen Kongpakwattana, Ph.D.
Lecturer, Faculty of Pharmaceutical Sciences, Chulalongkorn University
Vahvistettu sähköpostiosoite verkkotunnuksessa chula.ac.th
Nimike
Viittaukset
Viittaukset
Vuosi
Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis
K Kengkla, K Kongpakwattana, S Saokaew, A Apisarnthanarak, ...
Journal of Antimicrobial Chemotherapy 73 (1), 22-32, 2018
1662018
A systematic review of the burden of multidrug-resistant healthcare-associated infections among intensive care unit patients in Southeast Asia: the rise of multidrug-resistant …
N Teerawattanapong, P Panich, D Kulpokin, SN Ranong, ...
infection control & hospital epidemiology 39 (5), 525-533, 2018
1022018
Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta‐analysis
K Kongpakwattana, R Sawangjit, I Tawankanjanachot, JS Bell, SN Hilmer, ...
British journal of clinical pharmacology 84 (7), 1445-1456, 2018
742018
Global economic evaluations of rotavirus vaccines: A systematic review
S Kotirum, N Vutipongsatorn, K Kongpakwattana, R Hutubessy, ...
Vaccine 35 (26), 3364-3386, 2017
402017
A real-world evidence analysis of associations among costs, quality of life, and disease-severity indicators of Alzheimer’s disease in Thailand
K Kongpakwattana, C Dejthevaporn, O Krairit, P Dilokthornsakul, ...
Value in Health 22 (10), 1137-1145, 2019
272019
Comparative efficacy and safety of warfarin care bundles and novel oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis
SS Ng, NM Lai, S Nathisuwan, NK Jahan, P Dilokthornsakul, ...
Scientific Reports 10 (1), 662, 2020
222020
Application of discrete-event simulation in health technology assessment: a cost-effectiveness analysis of Alzheimer’s disease treatment using real-world evidence in Thailand
K Kongpakwattana, N Chaiyakunapruk
Value in Health 23 (6), 710-718, 2020
182020
Cost-effectiveness analysis of non-statin lipid-modifying agents for secondary cardiovascular disease prevention among statin-treated patients in Thailand
K Kongpakwattana, Z Ademi, T Chaiyasothi, S Nathisuwan, E Zomer, ...
Pharmacoeconomics 37, 1277-1286, 2019
142019
Estimating the productivity burden of pediatric pneumococcal disease in Thailand
T Ounsirithupsakul, P Dilokthornsakul, K Kongpakwattana, Z Ademi, ...
Applied health economics and health policy 18, 579-587, 2020
82020
“From safe source to safe sink” development of colorimetric assay for gabapentin in bulk drug and capsules using naturally derived genipin
W Winotapun, K Kongpakwattana, S Dejpittayanunt, ...
Talanta 99, 997-1003, 2012
82012
Compliance and persistence with Alzheimer’s disease treatment: a retrospective analysis of multiregional hospital databases in Thailand
K Kongpakwattana, P Dilokthornsakul, C Dejthevaporn, O Pattanaprateep, ...
Journal of Medical Economics 22 (1), 26-34, 2019
72019
Clinical and economic burden of postsurgical complications of high-risk surgeries: a cohort study in Thailand
K Kongpakwattana, P Dilokthornsakul, T Dhippayom, N Chaiyakunapruk
Journal of Medical Economics 23 (10), 1046-1052, 2020
42020
Compliance and persistence with Alzheimer’s disease treatment: a retrospective analysis of multiregional hospital databases in Thailand
K Kongpakwattana, P Dilokthornsakul, C Dejthevaporn, O Pattanaprateep, ...
Value in Health 21, S94, 2018
42018
How do we translate gaps and unmet needs of blood management for thalassemia into a collaborative implementation framework?
C Limwongse, P Rojnuckarin, P Kupatawintu, A Thongthaisin, ...
Transfusion Medicine 33 (6), 497-502, 2023
12023
Implementing the Implementation Framework for Telemedicine to Address Non-Communicable Diseases in Thailand: What We Have Learned
MD Pairoj Chattranukulchai, MD Nuntakorn Thongtang, ...
J Med Assoc Thai 106 (1), 102-5, 2023
2023
Donepezil cost effective for Alzheimer’s disease in Thailand
K Kongpakwattana
PharmacoEconomics & Outcomes News 850, 17-4, 2020
2020
PIH22 ESTIMATING THE PRODUCTIVITY BURDEN OF PEDIATRIC PNEUMOCOCCAL DISEASE IN THAILAND
T Ounsirithupsakul, N Chaiyakunapruk, P Dilokthornsakul, ...
Value in Health 22, S631, 2019
2019
ESTIMATING THE PRODUCTIVITY BURDEN OF PEDIATRIC PNEUMOCOCCAL DISEASE IN THAILAND
T Ounsirithupsakul, N Chaiyakunapruk, P Dilokthornsakul, ...
VALUE IN HEALTH 22, S631-S631, 2019
2019
PCV62 ECONOMIC EVALUATION AND NETWORK META-ANALYSIS OF NON-STATIN THERAPY AMONG STATIN-TREATED PATIENTS IN THAILAND
K Kongpakwattana, Z Ademi, T Chaiyasothi, S Nathisuwan, E Zomer, ...
Value in Health 22, S552, 2019
2019
Direct medical costs are major driver of AD costs in Thailand
K Kongpakwattana
PharmacoEconomics & Outcomes News 835, 13-24, 2019
2019
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20